METHOD OF POST-TRAUMATIC NEURODYSTROPHIC SYNDROME Russian patent published in 2009 - IPC A61K31/4152 A61K31/5513 A61K31/14 A61K31/4415 A61K31/355 A61K31/593 A61K36/835 A61P19/10 A61H1/00 A61N5/00 

FIELD: medicine; traumatology and neurology.

SUBSTANCE: treatment of post-traumatic neurodystrophic syndrome (PNDS) involves medicament therapy by non-steroid anti-inflammatory medicine combined with hypnotic and sedative drugs, antocholinesterse and vasoactive medicines, B group vitamins, biostimulators, as well as physiotherapy and remedial gymnastics. Additionally 2 ml of Bondronat bisphosphonate per 200 ml of physiological solution is injected intravenously by drop infusion for 1 hour twice over 5 day interval, 200 MU of Miamalcic nasal spray once per day for 6-8 weeks, 12.0 ml of 300 unit berlition per 200 ml of physiological solution is injected intravenously once per day for 5 days and later orally by one 0.3 g pill twice per day for 2 months, Calcium D3 Nicomed drug is administered orally by 1 pill twice per day in morning and evening for 3 months, E vitamin is administered by 1-2 drops three times per day. Additionally manual therapy of damaged segment in post-isometric relaxation mode is performed daily for 7 days.

EFFECT: reduced term of treatment due to pathological circle breakage in disease pathogenesis at the stage of progressing patchy osteoporosis.

1 ex